TipRanks
Mirum Pharmaceuticals Inc (DE:08D)
XETRA:08D
Germany Market
08D
Mirum Pharmaceuticals
RESEARCH TOOLSreports

Mirum Pharmaceuticals (08D) Stock News & Sentiment

0 Followers
Buy Rating Backed by Strong Rare Liver Disease Franchise, Expanding Commercial Footprint, and Favorable Risk‑Reward at Mirum Pharmaceuticals
Premium
Ratings
Buy Rating Backed by Strong Rare Liver Disease Franchise, Expanding Commercial Footprint, and Favorable Risk‑Reward at Mirum Pharmaceuticals
2d ago
MIRM
Mirum Therapeutics Reaffirmed as Top Pick as Analyst Hikes Price Target to $195 on Strong Clinical and Regulatory Wins
Premium
Ratings
Mirum Therapeutics Reaffirmed as Top Pick as Analyst Hikes Price Target to $195 on Strong Clinical and Regulatory Wins
3d ago
MIRM
Mirum’s Brellovitug Phase 3 Success Signals Transformational Growth
Premium
Company Announcements
Mirum’s Brellovitug Phase 3 Success Signals Transformational Growth
3d ago
8K
MIRM
Mirum’s AZURE-3 Trial: A New Switch Strategy in Chronic Hepatitis D
Premium
Company Announcements
Mirum’s AZURE-3 Trial: A New Switch Strategy in Chronic Hepatitis D
21d ago
MIRM
Mirum Pharmaceuticals Announces New Chief Medical Officer Appointment
Premium
Company Announcements
Mirum Pharmaceuticals Announces New Chief Medical Officer Appointment
23d ago
8K
MIRM
Mirum Pharmaceuticals Earnings Call Highlights Growth Momentum
Premium
Company Announcements
Mirum Pharmaceuticals Earnings Call Highlights Growth Momentum
1M ago
MIRM
Mirum Reaffirmed as Top Pick on Zilurgisertib’s Differentiated FOP Profile; Ramakanth Maintains $140 Price Target
Premium
Ratings
Mirum Reaffirmed as Top Pick on Zilurgisertib’s Differentiated FOP Profile; Ramakanth Maintains $140 Price Target
1M ago
MIRM
More DE:08D News >

08D News on the Web

Mirum Pharmaceuticals price target raised to $130 from $123 at Baird
TipRanks News
Bullish
Mirum To Announce Topline Results From Phase 3 AZURE-1 Study For Brelovitug
rttnews
Bullish
FDA Approves Mirum Pharmaceuticals' Atebrioz for Rare Bone Disorder, Ticker MIRM Reacts
GuruFocus News
Bullish
Mirum Pharmaceuticals, Inc. at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
Mirum Pharmaceuticals, Inc. at Citi Biopharma Back to School Summit Transcript
GuruFocus News
Neutral
TANG CAPITAL MANAGEMENT LLC Buys Nano Dimension Ltd (NNDM) -- Shares Look 69% Undervalued on GF ...
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM) and Encompass Health (EHC)
TipRanks News
Bullish
Mirum treatment of primary sclerosing cholangitis granted FDA orphan status
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
DE:08D
Sector Average
Media Buzz
This Week19 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:08D’s Media Buzz Sentiment?
19 articles about DE:08D were published this week. In an average week, 2 articles are published.
    What is DE:08D’s weekly average amount of articles?
    In an average week, 2 articles about DE:08D are published.
      What is DE:08D’s News Sentiment?
      100% of articles about DE:08D were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SMMTSummit Therapeutics
        CDNACareDx
        ARGXArgenx Se
        MEOBFMesoblast Limited
        KODKodiak Sciences
        Showing the stocks with the most bullish news sentiment over the past week